Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

RedBox Rx vs Teleios Health

RedBox Rx
Graded #108

Higher grade

vs+10
Teleios Health
Graded #328

Lower grade

The verdict

RedBox Rx takes it — 70.2/100 to 60.2/100.

RedBox Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RedBox Rx is a US telehealth pharmacy (parent company Hy-Vee) offering compounded GLP-1 weight management with flat, dose-independent pricing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleios Health +42
42
84
Dose & formulationRedBox Rx +19
83
64
Clinical oversightRedBox Rx +44
93
49
Labs & monitoringRedBox Rx +36
84
48
FulfillmentRedBox Rx +30
72
42
Contract termsTeleios Health +14
41
55
RedBox Rx · left barTeleios Health · right bar

The numbers

MetricRedBox RxTeleios Health
WeighScore70.2/10060.2/100
GradeCC
Scorecard rank#108#328
Semaglutide$269/mo (all doses, 6-month plan, compounded)$99/mo (starting dose, compounded)
Tirzepatide$429/mo$139/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
RedBox Rx

Graded #108 · C

Strengths

  • Flat, dose-independent pricing on both semaglutide and tirzepatide
  • Offers both weekly injections and daily oral tablets
  • Includes unlimited provider follow-ups, a metabolic panel and a dietitian session
  • Backed by grocery-pharmacy parent company Hy-Vee

Where it loses points

  • Does not serve every state (for example Mississippi is excluded)
  • Does not publicly name its compounding pharmacy
Teleios Health

Graded #328 · C

Strengths

  • Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
  • Compounded tirzepatide from a competitive $139/mo floor
  • Markets physician (MD/DO) prescribing rather than an NP-only model
  • Clean meta-tag and SEO implementation

Where it loses points

  • Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
  • No named medical director, physician, or corporate entity disclosed
  • Year founded unknown — a newer floor-price entrant warranting extra scrutiny
  • No LegitScript, NABP, or SOC 2 trust signal found
  • Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard